RICB Diagnostics' AIMME platform provides point‑of‑care quantitative detection of oncogenic biomarkers using an antibody‑functionalized BIO‑FET silicon nano‑chip. A disposable detection card and handheld reader deliver microliter blood sample results in minutes, transmitting calibrated readouts via Bluetooth to a smartphone app with secure EHR integration. The system serves oncology clinics, primary‑care physicians, point‑of‑care labs, and at‑home screening programs.
Funding
Funding not disclosed
Founders
Product
Problem
Current in‑vitro cancer screening relies on centralized laboratory assays that are time‑consuming, require venous draws, and need scheduled appointments, limiting rapid access to quantitative oncomarker results for both patients and clinicians.
Solution
RICB DIAGNOSTICS’ AIMME platform delivers point‑of‑care, quantitative detection of oncogenic biomarkers using an antibody‑mobilized BIO‑FET silicon nano‑chip. A disposable detection card receives a small blood sample prepared with a kit, and the integrated nano‑sensor generates an electrical read‑out that is captured by a handheld reader. The reader transmits the data via Bluetooth to a smartphone application, which processes the signal with calibrated algorithms and presents clear biomarker concentrations. This workflow reduces turnaround time from hours to minutes, eliminates the need for bulky lab equipment, and enables immediate clinical decision‑making or at‑home screening. The system complies with IVD standards and supports secure data handling for integration with electronic health records.
Target Audience
The primary customers are oncology clinics, primary‑care physicians, and point‑of‑care diagnostic labs seeking rapid, quantitative cancer biomarker testing, as well as health‑tech platforms that enable at‑home screening for high‑risk patients.
Features
- Antibody‑functionalized BIO‑FET silicon nano‑chip providing label‑free, high‑sensitivity electrical detection of specific oncomarkers
- Disposable detection card with low‑volume (microliter) blood sample requirement and integrated preparation kit
- Portable reader unit with on‑board analog‑to‑digital conversion and Bluetooth Low Energy (BLE) connectivity
- Smartphone evaluation software that applies calibrated signal‑processing algorithms to deliver quantitative biomarker readouts and trend visualizations
- Real‑time, end‑to‑end encrypted data transmission compatible with HL7/FHIR interfaces for EHR integration
- Battery‑operated design supporting up to 200 tests per charge, suitable for clinic, pharmacy, or home use
- Built‑in quality‑control checks (sensor integrity, temperature monitoring) to ensure assay reliability across environments